HLS Therapeutics Inc (DE:74D)

HLS Therapeutics Inc Financial Statements


HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 1.96%. HLS Therapeutics Inc is scheduled to report earnings on March 23, 2023, and the estimated EPS forecast is €-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 15.53M$ 14.56M$ 15.69M$ 15.06M$ 14.95M
Gross Profit$ 14.38M$ 13.60M$ 14.57M$ 13.88M$ 14.05M
EBIT$ -7.41M$ -1.75M$ -1.73M$ 67.00K$ -317.00K
EBITDA$ 1.08M$ 6.64M$ 6.32M$ 7.44M$ 7.16M
Net Income Common Stockholders$ -9.14M$ -3.62M$ -4.19M$ -1.98M$ -2.20M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 21.16M$ 22.66M$ 21.18M$ 21.74M$ 21.35M
Total Assets$ 266.63M$ 270.52M$ 275.90M$ 283.91M$ 296.10M
Total Debt$ 91.63M$ 94.63M$ 97.57M$ 100.03M$ 102.83M
Net Debt$ 70.47M$ 71.97M$ 76.39M$ 78.30M$ 81.48M
Total Liabilities$ 122.23M$ 111.50M$ 115.17M$ 119.21M$ 126.27M
Stockholders Equity$ 144.40M$ 159.03M$ 160.74M$ 164.70M$ 169.83M
Cash Flow
Free Cash Flow$ 3.43M$ 5.72M$ 3.56M$ 3.35M$ -817.00K
Operating Cash Flow$ 3.51M$ 5.76M$ 3.98M$ 3.55M$ 1.72M
Investing Cash Flow$ -81.00K$ -35.00K$ -422.00K$ -202.00K$ -2.53M
Financing Cash Flow$ -4.80M$ -4.30M$ -4.17M$ -2.88M$ -1.08M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis